US EditionSurmodics launches Pounce XL thrombectomy system
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Surmodics announces commercial release of Pounce XL thrombectomy system - Interventional News
Surmodics has announced the commercial release of the Pounce XL thrombectomy system, the latest in a suite of Pounce thrombectomy systems that provide endovascular removal of acute or chronic clot from peripheral arteries. Intended for removal of thrombi and emboli from peripheral arteries ranging from 5.5–10mm in diameter, sizes typical of iliac and femoral arteries, the Pounce XL thrombectomy system accompanies the Pounce and Pounce low-prof…
Surmodics Begins Full Commercial Release of Pounce XL Thrombectomy System - Endovascular Today
April 3, 2025—Surmodics, Inc. announced the full commercial release of the Pounce XL thrombectomy system. Pounce XL is intended for the endovascular removal of acute and chronic thrombi and emboli from peripheral arteries ranging from 5.5 to 10 mm in diameter—sizes typical of iliac and femoral arteries, noted the company. According to Surmodics, the Pounce XL complements the company’s Pounce system and Pounce LP low-profile system, which are int…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage